Lincoln Pharmaceuticals Limited
NSE:LINCOLN.NS
Overview | Financials
Company Name | Lincoln Pharmaceuticals Limited |
Symbol | LINCOLN.NS |
Currency | INR |
Price | 659.3 |
Market Cap | 13,205,581,210 |
Dividend Yield | 0.25% |
52-week-range | 534.8 - 811.85 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Mahendrabhai Gulabdas Patel |
Website | https://www.lincolnpharma.com |
An error occurred while fetching data.
About Lincoln Pharmaceuticals Limited
Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally. The company's product portfolio includes dermatologist preparations, gynecological products, gastrointestinal ranges, otology products, and phosphodiesterase type 5 inhibitor and general anesthetics. It provides products in the areas of cough and cold, anti-allergic, and anti-asthmatics; sterile
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD